---
title: 'Corrigendum to "mFOLFOX6 versus mFOLFOX6Â + aflibercept as neoadjuvant treatment
  in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal
  Cancer Study Group (CAO/ARO/AIO 0214) and the ABCSG (R-06)": [ESMO Open 9 (2024)
  103703]'
date: '2025-02-22'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39986704/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250223170759&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: No ...
disable_comments: true
---
No ...